Skip to content
PeptideAgent

Compounding pharmacies in New Mexico

By the PeptideAgent Editorial Team. Draft, pending editorial review.  Last verified

The New Mexico Board of Pharmacy (Regulation and Licensing Department) regulates compounding pharmacies in New Mexico. Compounded GLP-1 limited. How to check a pharmacy's license, plus verified listings.

New Mexico at a glance

503A framework
Follows the federal 503A framework
Telehealth prescribing
Regulatory: Telehealth allowed
Asynchronous prescribing
Regulatory: Async unclear
Compounded GLP-1 access
Regulatory: Compounded GLP-1 limited

Verified compounding pharmacies serving New Mexico

No verified compounding pharmacies serving New Mexico are listed yet. A provider appears here only after it passes the verification checklist, and those checks are still under way.

Looking for care now? Start with what the law allows where you live, then how a legitimate prescription works.

Run a pharmacy, clinic, or telehealth service? Apply for a listing.

Who regulates compounding pharmacies in New Mexico

The New Mexico Board of Pharmacy regulates pharmacy under the Pharmacy Act (NMSA 1978, sections 61-11-1 and following) and Title 16, Chapter 19 of the New Mexico Administrative Code. 16.19.36 NMAC governs compounded sterile preparations: it requires facilities, environmental monitoring, and written procedures consistent with USP chapter 797, sets minimum dedicated compounding space, and requires training of everyone who performs or oversees sterile compounding. The Board inspects sterile compounders by risk category and uses a separate nonresident sterile pharmacy application for out-of-state pharmacies that ship sterile preparations into New Mexico. Under the Pharmacy Act, NMSA 1978 section 61-11-2 defines a nonresident pharmacy as any pharmacy located outside New Mexico that ships, mails, or delivers drugs into New Mexico, and section 61-11-14 requires anyone who engages in an activity in the state requiring Board licensure to obtain the proper license, listing nonresident pharmacy as a license class. New Mexico has no state bulks list; peptide eligibility follows the federal 503A framework. [1] [2] [3] [4] [5] [7]

Compounded GLP-1 access in New Mexico

Because compounded GLP-1 injections are sterile preparations, an out-of-state pharmacy shipping them into New Mexico must hold the Board's nonresident sterile licensure and meet 16.19.36 NMAC standards. [4] [5] [10]

Research use only sellers in New Mexico

The New Mexico Drug, Device and Cosmetic Act (NMSA 1978, sections 26-1-1 and following) prohibits selling adulterated or misbranded drugs and limits dispensing of dangerous drugs to licensed practitioners and pharmacies. [6] [11]

New Mexico notes on specific peptides

  • Tirzepatide: Available branded by prescription. Compounded tirzepatide is limited to the federal patient specific exception since February 18, 2025, and any compounded injection must be prepared under 16.19.36 NMAC or an equivalent nonresident sterile license. [4] [10]

How to check a compounding pharmacy in New Mexico

  1. Search the New Mexico Board of Pharmacy (Regulation and Licensing Department) license lookup for the pharmacy by name. A pharmacy based elsewhere needs whatever license or registration New Mexico requires before it ships to you. [1] [2] [3] [4] [5] [7]
  2. Ask whether it operates as a 503A pharmacy or a 503B outsourcing facility, and confirm a 503B claim against FDA's outsourcing facility information (see the verification checklist).
  3. Confirm the peptide can be lawfully compounded: check its status on the regulatory tracker or its peptide page before paying.
  4. Walk away from any seller that labels a peptide "research use only" or "not for human consumption". See the research use only section above for what that means in New Mexico. [6] [11]

Common questions in New Mexico

Can an out-of-state pharmacy ship compounded injectable peptides to me in New Mexico?

Only if it holds New Mexico nonresident licensure, and for sterile preparations such as injectable peptides the Board uses a separate nonresident sterile application. Check the Board's license lookup before ordering. [1] [3] [5]

Can a New Mexico pharmacy compound BPC-157?

No, not from bulk today. BPC-157 is not on the 503A bulks list. PCAC's July 2026 recommendation is advisory, and until FDA publishes a final rule a 503A pharmacy has no federal basis to compound it from bulk. State boards cannot authorize what federal law does not. Peptides still in FDA Category 2 cannot be compounded either. [7] [8] [9]

All peptide legal questions for New Mexico

Sources

  1. [1]New Mexico Board of Pharmacy (Regulation and Licensing Department)
  2. [2]NMSA 1978, section 61-11-2, Pharmacy Act definitions (nonresident pharmacy)
  3. [3]NMSA 1978, section 61-11-14, Pharmacy licensure; classes of licenses; requirements; fees; revocation
  4. [4]16.19.36 NMAC, Compounded sterile preparations
  5. [5]New Mexico Board of Pharmacy: nonresident sterile pharmacy application (2022)
  6. [6]New Mexico Drug, Device and Cosmetic Act, NMSA 1978, Chapter 26, Article 1
  7. [7]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA
  8. [8]FDA: Certain bulk drug substances for use in compounding may present significant safety risks (503A and 503B category lists)FDA
  9. [9]FDA: Pharmacy Compounding Advisory CommitteeFDA
  10. [10]FDA: concerns with unapproved GLP-1 drugs used for weight loss, including shortage resolution and compounding grace periodsFDA
  11. [11]21 U.S.C. 331, Prohibited acts